New data on the effectiveness of liver cell transplantation in patients with Crigler-Najjar syndrome
- Authors: Plaksa I.L.
- Issue: Vol 3, No 4 (2008)
- Pages: 24-26
- Section: Clinical Trials
- URL: https://genescells.ru/2313-1829/article/view/200185
- ID: 200185
Cite item
Open Access
Access granted
Full Text
References
- Fox I.S., Chowdhury J.R., Kaufman S.S. et al. Treatment of the Crigler-Najjar syndrom type I with hepatocyte transplantation. Engl. J. Med. 1998; 338: 1422-6.
- Kautman S.S., Wood R.P., Show P.W. jr., Markin R.S. Orthotopic liver transplantation for type I Crigler-Najjar syndrome. Hepatology 1986; 6: 1259-62.
- Sokal E.M., Silva E.S., Hermans D. Orthotopic liver transplantation for Crigler-Najjar type I disease in six children. Traspant. 1995; 60: 1035—58.
- Evans H.M., Kelly D.A., Me Kierman P.S., Hubscher S. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006; 43: 1109-17.
- Makouka L., Falk J.A., Falk R.E. Allogenic intrasplenic hepatocyte transplantation. Transplant. Proc. 1987; 19: 1002—3.
- Cubero E.S., Maganto P., Ortiz A. Hepatic proliferation in Gunn rats transplanted with hepatocytes. Cell Prolis. 2005; 38; 134-46.
- Wu Y.M., Joseph B., Gupta S. Immunosupression using mTOR inhibition mechanism affects replacement of rat liver with transplanted cells. Hepatology 2006; 44: 410—9.
- Dixit V., Darnasi R., Arthur M. et al. Cryopreserved microencapsulated hepatocytes-transplantation stadies in Gunn rats. Transplant. 1993; 55: 616—22.
- Liu Z.C., Chang T.M. Coencapsulation of hepatocytes and bone marrow stem cells. Int. J. Artif. Organs 2003; 26: 491—7.
Supplementary files
Supplementary Files
Action
1.
JATS XML
2.
Mechanisms of "utilization" of bilirubin in the liver
Download (111KB)
